IFTAP

gene
On this page

Also known as FLJ38678HEPISNWC

Summary

IFTAP (intraflagellar transport associated protein, HGNC:25142) is a protein-coding gene on chromosome 11p12, encoding Intraflagellar transport-associated protein (Q86VG3). Seems to play a role in ciliary BBSome localization, maybe through interaction with IFT-A complex.

This gene encodes a protein that was identified as a cellular interacting partner of non-structural protein 10 of the severe acute respiratory syndrome coronavirus (SARS-CoV). The encoded protein may function as a negative regulator of transcription. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 119710 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 24 total
  • MANE Select transcript: NM_138787

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25142
Approved symbolIFTAP
Nameintraflagellar transport associated protein
Location11p12
Locus typegene with protein product
StatusApproved
AliasesFLJ38678, HEPIS, NWC
Ensembl geneENSG00000166352
Ensembl biotypeprotein_coding
OMIM619270
Entrez119710

Gene structure

Transcript identifiers

Ensembl transcripts: 37 — 26 protein_coding, 8 nonsense_mediated_decay, 3 retained_intron

ENST00000334307, ENST00000347206, ENST00000446510, ENST00000524539, ENST00000527108, ENST00000528092, ENST00000530697, ENST00000531554, ENST00000532470, ENST00000534635, ENST00000617650, ENST00000676885, ENST00000676921, ENST00000676979, ENST00000677097, ENST00000677116, ENST00000677156, ENST00000677406, ENST00000677623, ENST00000677673, ENST00000677808, ENST00000678060, ENST00000678480, ENST00000678950, ENST00000679022, ENST00000679072, ENST00000679127, ENST00000864503, ENST00000864504, ENST00000967886, ENST00000967887, ENST00000967888, ENST00000967889, ENST00000967890, ENST00000967891, ENST00000967892, ENST00000967893

RefSeq mRNA: 7 — MANE Select: NM_138787 NM_001276722, NM_001276723, NM_001276724, NM_001276725, NM_001276726, NM_001276727, NM_138787

CCDS: CCDS60762, CCDS7904

Canonical transcript exons

ENST00000334307 — 6 exons

ExonStartEnd
ENSE000013338773663328436633438
ENSE000021738363659450236594592
ENSE000021755223665901936659272
ENSE000033936683663605136636117
ENSE000035520723661008136610239
ENSE000035917773664801636648155

Expression profiles

Bgee: expression breadth ubiquitous, 247 present calls, max score 95.92.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.6807 / max 642.6341, expressed in 1651 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
11391715.06211648
1139180.4777264
1139190.118033
1139160.02296

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ventricle myocardiumUBERON:000656695.92gold quality
bronchial epithelial cellCL:000232895.18gold quality
myocardiumUBERON:000234994.68gold quality
left testisUBERON:000453394.57gold quality
cardiac muscle of right atriumUBERON:000337994.49gold quality
right testisUBERON:000453494.13gold quality
bronchusUBERON:000218594.11gold quality
right uterine tubeUBERON:000130293.87gold quality
oocyteCL:000002393.31gold quality
testisUBERON:000047393.27gold quality
right lobe of thyroid glandUBERON:000111993.26gold quality
left lobe of thyroid glandUBERON:000112093.19gold quality
thyroid glandUBERON:000204693.17gold quality
hindlimb stylopod muscleUBERON:000425293.05gold quality
heart left ventricleUBERON:000208493.02gold quality
cardiac ventricleUBERON:000208292.71gold quality
olfactory segment of nasal mucosaUBERON:000538692.45gold quality
right atrium auricular regionUBERON:000663192.25gold quality
cortical plateUBERON:000534392.23gold quality
cardiac atriumUBERON:000208192.04gold quality
heartUBERON:000094891.82gold quality
ganglionic eminenceUBERON:000402391.82gold quality
mucosa of paranasal sinusUBERON:000503091.62gold quality
apex of heartUBERON:000209891.57gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.47gold quality
pigmented layer of retinaUBERON:000178291.36gold quality
ventricular zoneUBERON:000305391.30gold quality
muscle of legUBERON:000138391.25gold quality
gastrocnemiusUBERON:000138891.23gold quality
spermCL:000001990.61gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7606no63.41
E-CURD-112no2.68
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

5 targeting IFTAP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-409-3P99.5066.331192
HSA-MIR-548B-3P99.3867.261000
HSA-MIR-451198.3267.971500

Literature-anchored findings (GeneRIF, showing 2)

  • identification of HEPIS as a protein that binds nsp10 of SARS-CoV (PMID:16157265)
  • The C11ORF74, interacts with the IFT-A complex via the IFT122 subunit and is accumulated at the distal tip in the absence of an IFT-A subunit IFT139, suggesting that at least a fraction of C11ORF74 molecules can be transported towards the ciliary tip by associating with the IFT-A complex, although its majority might be out of cilia at steady state. (PMID:30476139)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusIftapENSMUSG00000027165
rattus_norvegicusIftapENSRNOG00000037567

Protein

Protein identifiers

Intraflagellar transport-associated proteinQ86VG3 (reviewed: Q86VG3)

Alternative names: Protein HEPIS

All UniProt accessions (11): A0A7I2V427, A0A7I2V4A0, A0A7I2V4J5, A0A7I2V5I0, A0A7I2V5I8, A0A7I2V5V2, A0A7I2YQT1, B4DYW4, Q86VG3, E9PJ48, E9PPH4

UniProt curated annotations — full annotation on UniProt →

Function. Seems to play a role in ciliary BBSome localization, maybe through interaction with IFT-A complex.

Subunit / interactions. Interacts with IFT122; the interaction associates IFTAP with IFT-A complex.

Isoforms (2)

UniProt IDNamesCanonical?
Q86VG3-11yes
Q86VG3-22

RefSeq proteins (7): NP_001263651, NP_001263652, NP_001263653, NP_001263654, NP_001263655, NP_001263656, NP_620142* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR040028IFTAPFamily

Pfam: PF17722

UniProt features (3 total): chain 1, modified residue 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86VG3-F166.650.16

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 59

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 150 (showing top): GOBP_SINGLE_FERTILIZATION, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, AACYNNNNTTCCS_UNKNOWN, GOBP_MALE_GAMETE_GENERATION, GGAMTNNNNNTCCY_UNKNOWN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_ACROSOME_REACTION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ZHANG_BREAST_CANCER_PROGENITORS_UP, GOBP_FERTILIZATION, MODULE_48, MODULE_95, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, STAT1_01

GO Biological Process (3): spermatogenesis (GO:0007283), acrosome reaction (GO:0007340), fertilization (GO:0009566)

GO Molecular Function (2): intraciliary transport particle A binding (GO:0120160), protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), 9+0 non-motile cilium (GO:0097731)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
reproductive process2
developmental process involved in reproduction1
male gamete generation1
membrane fusion involved in acrosome reaction1
single fertilization1
acrosomal vesicle exocytosis1
sexual reproduction1
protein-containing complex binding1
binding1
cytoplasm1
cellular anatomical structure1
non-motile cilium1

Protein interactions and networks

STRING

412 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
IFTAPIFT122Q9HBG6739
IFTAPIFT43Q96FT9643
IFTAPOR52R1Q8NGF1582
IFTAPWDR19Q8NEZ3541
IFTAPC14orf119Q9NWQ9448
IFTAPC11orf91Q3C1V1434
IFTAPRCSD1Q6JBY9391
IFTAPCNBD2Q96M20377
IFTAPZNF397Q8NF99375
IFTAPDYNLRB1Q9NP97372
IFTAPTCP11L1Q9NUJ3370
IFTAPGTF2IRD1Q9UHL9362
IFTAPPRPSAP2O60256360
IFTAPLRFN1Q9P244358
IFTAPGARIN4Q8IYT1358

IntAct

22 interactions, top by confidence:

ABTypeScore
IFT43TULP3psi-mi:“MI:0914”(association)0.790
IFTAPPLK1psi-mi:“MI:0914”(association)0.640
IFTAPWDR19psi-mi:“MI:0914”(association)0.530
IFTAPBTF3psi-mi:“MI:0915”(physical association)0.510
IFTAPMFHAS1psi-mi:“MI:0407”(direct interaction)0.440
IFTAPpsi-mi:“MI:0915”(physical association)0.370
IFTAPbipApsi-mi:“MI:0915”(physical association)0.370
IFTAPSFRS5psi-mi:“MI:0915”(physical association)0.370
IFTAPPOLR2Apsi-mi:“MI:0915”(physical association)0.370
SLC10A1IFTAPpsi-mi:“MI:0915”(physical association)0.370
IFTAPSMARCC2psi-mi:“MI:0915”(physical association)0.370
IFTAPPPP1CCpsi-mi:“MI:0915”(physical association)0.370
IFT43TULP3psi-mi:“MI:0914”(association)0.350
IFTAPGNPATpsi-mi:“MI:0914”(association)0.350
IFT43TLE1psi-mi:“MI:0914”(association)0.350

BioGRID (45): WDR35 (Affinity Capture-MS), IFT140 (Affinity Capture-MS), WDR19 (Affinity Capture-MS), IFT122 (Affinity Capture-MS), PLK1 (Affinity Capture-MS), IFT43 (Affinity Capture-MS), UBE2S (Affinity Capture-MS), C11orf74 (Affinity Capture-MS), WDR35 (Affinity Capture-MS), WDR19 (Affinity Capture-MS), IFT140 (Affinity Capture-MS), IFT122 (Affinity Capture-MS), PLK1 (Affinity Capture-MS), UBE2S (Affinity Capture-MS), C11orf74 (Reconstituted Complex)

ESM2 similar proteins: A0A1B0GTZ2, A0A1B0GVH6, A1DL98, A2RRY8, A3RM20, A4UHQ4, A6ZMG4, B0BK70, B3LLZ8, B6LI37, C7GWA2, C8ZEW0, O55527, O74982, P04861, P04862, P14253, P40167, P69738, Q04438, Q06616, Q0GBX8, Q1T763, Q2YDE5, Q3TTJ4, Q3URK1, Q3ZBP0, Q4R309, Q561K4, Q5R498, Q5SQS8, Q6PI97, Q6PKN7, Q6X1D3, Q86UF4, Q86VG3, Q8IZS5, Q8N9R6, Q8TAL5, Q8WWF3

Diamond homologs: Q3ZBP0, Q86VG3, Q9CQI4

SIGNOR signaling

2 interactions.

AEffectBMechanism
IFTAP“down-regulates activity”BTF3binding
“Non-structural protein 10”unknownIFTAPbinding

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance7
Likely benign2
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1585 predictions. Top by Δscore:

VariantEffectΔscore
11:36633282:A:AGacceptor_gain1.0000
11:36633282:AGAG:Aacceptor_gain1.0000
11:36633283:G:GGacceptor_gain1.0000
11:36633283:GA:Gacceptor_gain1.0000
11:36633283:GAGG:Gacceptor_gain1.0000
11:36648167:GGAAT:Gdonor_gain1.0000
11:36648168:G:Tdonor_gain1.0000
11:36659008:A:AGacceptor_gain1.0000
11:36659015:ATAG:Aacceptor_loss1.0000
11:36659016:T:Gacceptor_gain1.0000
11:36659016:TAGA:Tacceptor_loss1.0000
11:36659017:A:AGacceptor_gain1.0000
11:36659017:A:ATacceptor_loss1.0000
11:36659018:G:GGacceptor_gain1.0000
11:36659018:GA:Gacceptor_gain1.0000
11:36594774:G:GTdonor_gain0.9900
11:36594913:G:GTdonor_gain0.9900
11:36598097:CCTA:Cdonor_loss0.9900
11:36598099:TACC:Tdonor_loss0.9900
11:36598101:CCTG:Cdonor_loss0.9900
11:36610075:TTGCA:Tacceptor_loss0.9900
11:36610076:TGCA:Tacceptor_loss0.9900
11:36610077:GCA:Gacceptor_loss0.9900
11:36610078:CA:Cacceptor_loss0.9900
11:36610079:A:AGacceptor_gain0.9900
11:36610079:AGAT:Aacceptor_loss0.9900
11:36610080:G:GAacceptor_gain0.9900
11:36610080:G:GCacceptor_loss0.9900
11:36610080:GAT:Gacceptor_gain0.9900
11:36610080:GATA:Gacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000026201 (11:36631884 G>A), RS1000081251 (11:36648882 C>T), RS1000104905 (11:36602349 A>C,G), RS1000257013 (11:36641919 G>T), RS1000286519 (11:36642430 G>A), RS1000409879 (11:36618788 T>C), RS1000441646 (11:36632052 G>C), RS1000478527 (11:36635924 A>G), RS1000558040 (11:36654489 A>G), RS1000616544 (11:36595746 A>T), RS1000707417 (11:36597896 C>G,T), RS1000775627 (11:36648678 T>A), RS1000785938 (11:36635552 T>G), RS1000816170 (11:36604781 A>G), RS1000862385 (11:36618526 G>A)

Disease associations

OMIM: gene MIM:619270 | disease phenotypes: MIM:601457, MIM:603554

GenCC curated gene-disease

Mondo (2): severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive (MONDO:0011086), Omenn syndrome (MONDO:0011338)

Orphanet (2): Severe combined immunodeficiency due to complete RAG1/2 deficiency (Orphanet:331206), Omenn syndrome (Orphanet:39041)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST001034_2Cutaneous nevi2.000000e-06
GCST003944_17Hepcidin/ferritin ratio2.000000e-06
GCST005588_1Idiopathic dilated cardiomyopathy3.000000e-06
GCST006484_12Type 2 diabetes2.000000e-06
GCST008526_9Coffee consumption6.000000e-07
GCST011836_4Cervical high-risk human papilloma virus infection (persistent)7.000000e-07

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0000625nevus
EFO:0007901hepcidin:ferritin ratio
EFO:0009094idiopathic dilated cardiomyopathy
EFO:0006781coffee consumption measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
C563311Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression3
Air Pollutantsdecreases expression, increases abundance, increases expression2
Particulate Matterdecreases reaction, increases expression, decreases expression, increases abundance2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamideincreases expression1
dicrotophosdecreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
abrinedecreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amidedecreases reaction, increases expression1
jinfukangaffects cotreatment, increases expression1
Sunitinibdecreases expression1
Vorinostatincreases expression1
Acetaminophendecreases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Vehicle Emissionsdecreases reaction, increases expression1
Benzo(a)pyrenedecreases methylation, increases methylation1
Cisplatinaffects cotreatment, increases expression1
Doxorubicindecreases expression1
Estradioldecreases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Valproic Aciddecreases methylation, increases expression1
Aflatoxin B1decreases methylation1
Cadmium Chloridedecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

3 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT07284641PHASE2RECRUITINGHematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
NCT01186913Not specifiedENROLLING_BY_INVITATIONNatural History Study of SCID Disorders
NCT01346150Not specifiedUNKNOWNPatients Treated for SCID (1968-Present)